TEACHERS ADVISORS, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 211 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$10,789,000
+99.6%
283,477
+125.6%
0.01%
+62.5%
Q4 2018$5,405,000
-41.4%
125,637
-33.1%
0.01%
+33.3%
Q3 2018$9,230,000
+275.2%
187,798
+144.6%
0.01%
+100.0%
Q2 2018$2,460,000
+9.8%
76,768
+6.7%
0.00%0.0%
Q1 2018$2,240,000
-31.8%
71,9200.0%0.00%
-25.0%
Q4 2017$3,283,000
-61.2%
71,920
-68.1%
0.00%
-63.6%
Q3 2017$8,463,000
-21.2%
225,383
+0.1%
0.01%
-26.7%
Q2 2017$10,739,000
+10.7%
225,141
+5.8%
0.02%
+7.1%
Q1 2017$9,703,000
+378.0%
212,792
+238.5%
0.01%
+366.7%
Q4 2016$2,030,000
+0.2%
62,854
+6.2%
0.00%0.0%
Q3 2016$2,026,000
+2.8%
59,196
+1.3%
0.00%0.0%
Q2 2016$1,971,000
-31.5%
58,443
+7.6%
0.00%
-40.0%
Q1 2016$2,879,000
-77.1%
54,337
-66.9%
0.01%
-79.2%
Q4 2015$12,597,000
+472.6%
164,040
+206.4%
0.02%
+500.0%
Q3 2015$2,200,000
-41.4%
53,531
+0.9%
0.00%
-42.9%
Q2 2015$3,753,000
-17.2%
53,065
+4.0%
0.01%
-12.5%
Q1 2015$4,535,000
+2.8%
51,042
+2.6%
0.01%0.0%
Q4 2014$4,411,000
-8.5%
49,7480.0%0.01%
-20.0%
Q3 2014$4,822,000
+4.5%
49,748
-0.9%
0.01%
+11.1%
Q2 2014$4,613,000
+62.5%
50,222
+23.9%
0.01%
+50.0%
Q1 2014$2,838,000
+24.1%
40,548
+1.9%
0.01%
+20.0%
Q4 2013$2,287,000
+24.8%
39,776
+4.4%
0.01%0.0%
Q3 2013$1,832,000
+73.3%
38,086
+4.5%
0.01%
+66.7%
Q2 2013$1,057,00036,4330.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders